Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Lobular 1 Breast Neoplasms 1

Interventions

pembrolizumab 36 Bevacizumab 25 Cyclophosphamide 22 Blood Specimen Collection 18 Nivolumab 17 Carboplatin 15 Standard of Care 14 Paclitaxel 14 atezolizumab 13 Gemcitabine 13 Exercise 13 Pemetrexed 11 Fluorouracil 11 Doxorubicin 11 Cisplatin 11 Cetuximab 10 Radiotherapy 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Docetaxel 9 durvalumab 8 abemaciclib 8 Temozolomide 8 Surveys and Questionnaires 8 Rituximab 8 Prednisone 8 Biopsy 8 130-nm albumin-bound paclitaxel 8 olaparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Radiotherapy, Adjuvant × 90 days × Clear all

NCT07613151 2026-05-29

NAPOLI

Istituto Oncologico Veneto IRCCS

Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡